| MRAS / muscle RAS oncogene homolog / O08989* / O14807* / muscle and microspikes RAS* | ENSGALG00000011592 | 56 |
| H-RAS / P08642 / GTPase HRas GTPase HRas, N-terminally processed / HRAS* / Q61411* / P01112* / HRas proto-oncogene, GTPase* | ENSGALG00000029260 | 53 |
| H-RAS / P08642 / GTPase HRas GTPase HRas, N-terminally processed / HRAS* / Q61411* / P01112* / HRas proto-oncogene, GTPase* | ENSGALG00000034526 | 53 |
| KRAS / KRAS proto-oncogene, GTPase / P01116* / P32883* / GTPase KRas GTPase KRas, N-terminally processed* | ENSGALG00000030943 | 51 |
| NRAS / GTPase NRas precursor / P01111* / neuroblastoma ras oncogene* / NRAS proto-oncogene, GTPase* | ENSGALG00000026692 | 50 |
| RALA / RAS like proto-oncogene A / P11233* / P63321* / Ras-related protein Ral-A * | ENSGALG00000031893 | 46 |
| RALB / RAS like proto-oncogene B / P11234* / Q9JIW9* / Ras-related protein Ral-B * | ENSGALG00000026493 | 45 |
| RERG / RAS like estrogen regulated growth inhibitor / Q8R367* / Q96A58* / Ras-related and estrogen-regulated growth inhibitor * | ENSGALG00000028186 | 38 |
| ENSGALG00000027778 | 33 |
| GEM / GTP-binding protein GEM / P55040* / P55041* / GTP binding protein overexpressed in skeletal muscle* | ENSGALG00000032506 | 31 |
| RASL11A / RAS like family 11 member A / Q6IMB1* / Q6T310* / Ras-like protein family member 11A * | ENSGALG00000017099 | 31 |
| RASL12 / RAS like family 12 / Q08AT1* / Q9NYN1* / Ras-like protein family member 12 * | ENSGALG00000007349 | 29 |
| REM1 / RRAD and GEM like GTPase 1 / O35929* / O75628* / GTP-binding protein REM 1 * | ENSGALG00000045602 | 29 |
| RERGL / RERG like / Q9H628* / RERG/RAS-like* | ENSGALG00000013112 | 28 |
| ENSGALG00000007710 | 28 |
| RRAD / GTP-binding protein RAD / P55042* / Ras-related associated with diabetes* / RRAD, Ras related glycolysis inhibitor and calcium channel regulator* | ENSGALG00000005140 | 28 |
| RASL11B / RAS like family 11 member B / Q922H7* / Q9BPW5* / Ras-like protein family member 11B * | ENSGALG00000013948 | 25 |
